Cellular α-synuclein pathology is associated with bioenergetic dysfunction in Parkinson's iPSC-derived dopamine neurons

Cellular α-synuclein pathology is associated with bioenergetic dysfunction in Parkinson's iPSC-derived dopamine neurons

Parkinson's disease (PD) is the second most common neurodegenerative disorder and a central role for α-Synuclein (αSyn; SNCA) in disease aetiology has been proposed based on genetics and neuropathology. To better understand the pathological mechanisms of αSyn, we generated induced pluripotent s...

Bibliografske podrobnosti
Main Authors:	Zambon, F, Cherubini, M, Fernandes, HJR, Lang, C, Ryan, BJ, Volpato, V, Bengoa-Vergniory, N, Vingill, S, Attar, M, Booth, HDE, Haenseler, W, Vowles, J, Bowden, R, Webber, C, Cowley, SA, Wade-Martins, R
Format:	Journal article
Jezik:	English
Izdano:	Oxford University Press 2019

Podobne knjige/članki

Excess α-synuclein compromises phagocytosis in iPSC-derived macrophages.
od: Haenseler, W, et al.
Izdano: (2017)

Excess α-synuclein compromises phagocytosis in iPSC-derived macrophages
od: Walther Haenseler, et al.
Izdano: (2017-08-01)

Calcium dysregulation combined with mitochondrial failure and electrophysiological maturity converge in Parkinson’s iPSC-dopamine neurons
od: Beccano-Kelly, DA, et al.
Izdano: (2023)

Calcium dysregulation combined with mitochondrial failure and electrophysiological maturity converge in Parkinson’s iPSC-dopamine neurons
od: Dayne A. Beccano-Kelly, et al.
Izdano: (2023-07-01)

Studying α-Synuclein pathology using iPSC-derived dopaminergic neurons
od: Zambon, F
Izdano: (2017)

MAPT genetic variation and neuronal maturity alter isoform expression affecting axonal transport in iPSC-derived dopamine neurons.
od: Beevers, J, et al.
Izdano: (2017)

Single-cell sequencing of iPSC-dopamine neurons reconstructs disease progression and identifies HDAC4 as a regulator of Parkinson cell phenotypes
od: Lang, C, et al.
Izdano: (2018)

RNA sequencing reveals MMP2 and TGFB1 downregulation in LRRK2 G2019S Parkinson's iPSC-derived astrocytes
od: Booth, H, et al.
Izdano: (2019)

ER stress and autophagic perturbations lead to elevated extracellular α-Synuclein in GBA-N370S Parkinson's iPSC-derived dopamine neurons
od: Fernandes, H, et al.
Izdano: (2016)

Addressing variability in iPSC-derived models of human disease: guidelines to promote reproducibility
od: Viola Volpato, et al.
Izdano: (2020-01-01)

MAPT Genetic Variation and Neuronal Maturity Alter Isoform Expression Affecting Axonal Transport in iPSC-Derived Dopamine Neurons
od: Joel E. Beevers, et al.
Izdano: (2017-08-01)

Targeting alpha-synuclein as a therapy for Parkinson’s disease
od: Fields, CR, et al.
Izdano: (2019)

ER Stress and Autophagic Perturbations Lead to Elevated Extracellular α-Synuclein in GBA-N370S Parkinson's iPSC-Derived Dopamine Neurons
od: Hugo J.R. Fernandes, et al.
Izdano: (2016-03-01)

RNA sequencing reveals MMP2 and TGFB1 downregulation in LRRK2 G2019S Parkinson's iPSC-derived astrocytes
od: Heather D.E. Booth, et al.
Izdano: (2019-09-01)

Targeting Alpha-Synuclein as a Therapy for Parkinson’s Disease
od: Carroll Rutherford Fields, et al.
Izdano: (2019-12-01)

CO-CULTURE OF Α-SYNUCLEIN-TREATED IPSC-DERIVED DOPAMINERGIC NEURONS AND MICROGLIA AS AN IN VITRO MODEL OF PARKINSON’S DISEASE
od: Patricia Villegas-Zafra, et al.
Izdano: (2023-10-01)

Bioenergetic deficits in Huntington’s disease iPSC-derived neural cells and rescue with glycolytic metabolites
od: Kedaigle, Amanda J, et al.
Izdano: (2020)

Alpha-synuclein oligomers: a new hope.
od: Bengoa-Vergniory, N, et al.
Izdano: (2017)

Alpha-synuclein induces the unfolded protein response in Parkinson's disease SNCA triplication iPSC-derived neurons
od: Heman-Ackah, S, et al.
Izdano: (2017)

Alpha-synuclein proximity ligation assay (AS-PLA) in brain sections to probe for alpha-synuclein oligomers
od: Roberts, RF, et al.
Izdano: (2019)

Detection of pathological alpha-synuclein aggregates in human iPSC-derived neurons and tissue
od: Iva Stojkovska, et al.
Izdano: (2021-03-01)

REST protects dopaminergic neurons from mitochondrial and α-synuclein oligomer pathology in an alpha synuclein overexpressing BAC-transgenic mouse model
od: Ryan, BJ, et al.
Izdano: (2021)

Lentiviral gene therapy vector with UCOE stably restores function in iPSC-derived neutrophils of a CDG patient.
od: Haenseler, W, et al.
Izdano: (2018)

Modeling of mitochondrial bioenergetics and autophagy impairment in MELAS-mutant iPSC-derived retinal pigment epithelial cells
od: Sujoy Bhattacharya, et al.
Izdano: (2022-06-01)

Pro-maturational effects of human iPSC-derived cortical astrocytes upon iPSC-derived cortical neurons
od: Anne Hedegaard, et al.
Izdano: (2020)

A patient-based iPSC-derived hepatocyte model of alcohol-associated cirrhosis reveals bioenergetic insights into disease pathogenesis
od: Bani Mukhopadhyay, et al.
Izdano: (2024-05-01)

The CIRM iPSC repository
od: Stephen S. Lin, et al.
Izdano: (2020-04-01)

CiRA iPSC seed stocks (CiRA's iPSC Stock Project)
od: Tadaaki Hanatani, et al.
Izdano: (2021-01-01)

In vitro Differentiation of Human iPSC-derived Cardiovascular Progenitor Cells (iPSC-CVPCs)
od: Agnieszka D’Antonio-Chronowska, et al.
Izdano: (2020-09-01)

Honing the double-edged sword: improving human iPSC-microglia models
od: Hedegaard, A, et al.
Izdano: (2020)

SNCA triplication Parkinson's patient's iPSC-derived DA neurons accumulate α-synuclein and are susceptible to oxidative stress.
od: Blake Byers, et al.
Izdano: (2011-01-01)

In vitro Differentiation of Human iPSC-derived Retinal Pigment Epithelium Cells (iPSC-RPE)
od: Agnieszka D’Antonio-Chronowska, et al.
Izdano: (2019-12-01)

Modelling and analysis of LRRK2 mutations in iPSC-derived dopaminergic neurons and astrocytes
od: Booth, H
Izdano: (2017)

Maturing iPSC-Derived Cardiomyocytes
od: Bor Luen Tang
Izdano: (2020-01-01)

iPSC for modeling neurodegenerative disorders
od: Valeria Valadez-Barba, et al.
Izdano: (2020-12-01)

Parkin and PINK1 Patient iPSC-Derived Midbrain Dopamine Neurons Exhibit Mitochondrial Dysfunction and α-Synuclein Accumulation
od: Sun Young Chung, et al.
Izdano: (2016-10-01)

Identification of bioactive metabolites in human iPSC-derived dopaminergic neurons with PARK2 mutation: Altered mitochondrial and energy metabolism
od: Okarmus, J, et al.
Izdano: (2021)

Modeling riboflavin transporter deficiency type 2: from iPSC-derived motoneurons to iPSC-derived astrocytes
od: Valentina Magliocca, et al.
Izdano: (2024-07-01)

Generation of iPSC line iPSC-FH2.1 in hypoxic conditions from human foreskin fibroblasts
od: María Questa, et al.
Izdano: (2016-03-01)

Induced pluripotent stem cell (iPSC)-derived dopaminergic models of Parkinson's disease.
od: Beevers, J, et al.
Izdano: (2013)